MedTrace Logo

Increasing Colorectal Cancer Screening Uptake With a Patient Navigator

NCT01506687 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 750

Last updated 2013-12-03

No results posted yet for this study

Summary

Patients who receive tailored navigation (consisting of a letter and patient navigation services) and get screened will be significantly greater than the control group who receives treatment as usual.

A majority of patients will opt for Fecal Occult Blood Testing (FOBT)as one of their preferred tests, after undergoing the "Patient Navigator" intervention and that proportion will be significantly greater than the group who opt for FOBT in the control group.

Conditions

Interventions

BEHAVIORAL

Health counselling by nurse navigator

Information on colorectal cancer and screening, assistance in selection of screening option and obtaining kit or colonoscopy referral

BEHAVIORAL

Usual primary care counselling

Usual care health counselling on colorectal cancer and screening options

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Cancer Care Ontario

    lead OTHER

Principal Investigators

  • Paul Ritvo, PHD · Cancer Care Ontario

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01506687 on ClinicalTrials.gov